Theory Financial LLC Abb Vie Inc. Transaction History

Theory Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $51,324 - $57,803	-373 Reduced 8.68%	3,923 $607,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $8,015 - $9,279	60 Added 1.42%	4,296 $640,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $15,767 - $18,909	-114 Reduced 2.62%	4,236 $685,000
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $9,908 - $12,597	72 Added 1.68%	4,350 $670,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $459,585 - $581,508	4,278 New	4,278 $579,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Theory Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Theory Financial LLC with notifications on news.